Author

Yasmine Tabdili

University of ArizonaPrimary ORCID profile (0000-0002-7022-3280 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Yasmine TabdiliiD1 paper · Johns Hopkins University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Chandrayee GhoshiD· 1 shared Eden Demissie Alamaw· 1 shared Electron KebebewiD· 1 shared Jiangnan HuiD· 1 shared Myriem BoufraqechiD· 1 shared Scott J. DixoniD· 1 shared Tejinder Pal KhaketiD· 1 shared Zhongyue Yang· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chandrayee GhoshORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Dual Targeting of BRAFV600E and Ferroptosis Results in Synergistic Anticancer Activity via Iron Overload and Enhanced Oxidative Stress

Jiangnan Hu, Chandrayee Ghosh, Tejinder Pal Khaket, Zhongyue Yang, Yasmine Tabdili, Eden Demissie Alamaw, Myriem Boufraqech, Scott J. Dixon, Electron Kebebew

This study shows that combining BRAFV600E inhibition with ferroptosis induction synergistically kills anaplastic thyroid cancer cells by increasing iron and oxidative stress.

Journal of Experimental & Clinical Cancer Research · Jan 7, 2026Peer-reviewedCancer Biology